Home First Finance Company India Limited (BOM:543259)
India · Delayed Price · Currency is INR 1,279.15
+18.35 (1.46%)
At close: Aug 5, 2025
Marinus Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Interest and Dividend Income | 14,453 | 13,540 | 10,277 | 7,222 | 5,117 | 4,301 | Upgrade |
Total Interest Expense | 7,588 | 7,153 | 4,999 | 3,043 | 2,157 | 2,174 | Upgrade |
Net Interest Income | 6,865 | 6,388 | 5,278 | 4,179 | 2,960 | 2,127 | Upgrade |
Commissions and Fees | 614.6 | 452.99 | 99.33 | 104.08 | 13.18 | 16.74 | Upgrade |
Gain (Loss) on Sale of Investments | 400.77 | 400.77 | 324.74 | 178.81 | 136.72 | 120 | Upgrade |
Other Revenue | 955.77 | 862.54 | 627.64 | 380.37 | 678.34 | 439.35 | Upgrade |
Revenue Before Loan Losses | 8,836 | 8,104 | 6,330 | 4,843 | 3,789 | 2,703 | Upgrade |
Provision for Loan Losses | 345.41 | 284.12 | 253.16 | 211.99 | 240.64 | 314.68 | Upgrade |
| 8,491 | 7,820 | 6,077 | 4,631 | 3,548 | 2,389 | Upgrade | |
Revenue Growth (YoY) | 32.26% | 28.68% | 31.23% | 30.52% | 48.53% | 5.53% | Upgrade |
Salaries & Employee Benefits | 2,132 | 1,944 | 1,483 | 1,070 | 807.7 | 661.26 | Upgrade |
Cost of Services Provided | 61.16 | 61.16 | 58.17 | 36.99 | 18.03 | 12.84 | Upgrade |
Other Operating Expenses | 743.57 | 732.35 | 608.16 | 523.53 | 374.72 | 291.41 | Upgrade |
Total Operating Expenses | 3,101 | 2,893 | 2,267 | 1,721 | 1,276 | 1,042 | Upgrade |
Operating Income | 5,389 | 4,927 | 3,810 | 2,909 | 2,272 | 1,347 | Upgrade |
Pretax Income | 5,446 | 5,016 | 4,000 | 2,952 | 2,263 | 1,340 | Upgrade |
Income Tax Expense | 1,314 | 1,195 | 942.43 | 669.28 | 401.97 | 339.01 | Upgrade |
Net Income | 4,132 | 3,821 | 3,057 | 2,283 | 1,861 | 1,001 | Upgrade |
Net Income to Common | 4,132 | 3,821 | 3,057 | 2,283 | 1,861 | 1,001 | Upgrade |
Net Income Growth | 27.38% | 24.97% | 33.91% | 22.67% | 85.83% | 25.88% | Upgrade |
Shares Outstanding (Basic) | 92 | 89 | 88 | 88 | 88 | 81 | Upgrade |
Shares Outstanding (Diluted) | 94 | 91 | 91 | 91 | 91 | 82 | Upgrade |
Shares Change (YoY) | 3.48% | 0.04% | 0.22% | -0.01% | 10.16% | 9.28% | Upgrade |
EPS (Basic) | 44.68 | 42.83 | 34.65 | 26.01 | 21.26 | 12.37 | Upgrade |
EPS (Diluted) | 43.97 | 42.07 | 33.67 | 25.20 | 20.54 | 12.18 | Upgrade |
EPS Growth | 23.13% | 24.95% | 33.61% | 22.69% | 68.64% | 15.23% | Upgrade |
Free Cash Flow | - | -22,103 | -19,157 | -14,757 | -8,106 | -2,256 | Upgrade |
Free Cash Flow Per Share | - | -243.36 | -211.01 | -162.91 | -89.47 | -27.43 | Upgrade |
Dividend Per Share | - | 3.700 | 3.400 | 2.600 | - | - | Upgrade |
Dividend Growth | - | 8.82% | 30.77% | - | - | - | Upgrade |
Operating Margin | 63.47% | 63.01% | 62.69% | 62.83% | 64.04% | 56.39% | Upgrade |
Profit Margin | 48.67% | 48.86% | 50.31% | 49.30% | 52.45% | 41.93% | Upgrade |
Free Cash Flow Margin | - | -282.65% | -315.24% | -318.68% | -228.46% | -94.44% | Upgrade |
Effective Tax Rate | 24.13% | 23.83% | 23.56% | 22.67% | 17.76% | 25.29% | Upgrade |
Revenue as Reported | 16,531 | 15,392 | 11,565 | 7,956 | 5,957 | 4,892 | Upgrade |
Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.